| Name | ginsenoside Rh2 |
|---|---|
| Synonyms |
b-D-Glucopyranoside, (3b,12b,20R)-12,20-dihydroxydamm-24-en-3-yl
(3β,12β,20R)-12,20-Dihydroxydammar-24-en-3-yl β-D-glucopyranoside 20(R)-Rh2 20(SR)-Ginsenoside Rh2 (2R,3R,4S,5R,6R)-2-[[(10S,12S,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6 -methyl-ht-5-en-2-yl]-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,1 3,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxyme thyl)oxane-3,4,5-triol Ginsenoside-Rh2 (20R)Ginsenoside Rh2|||Ginsenoside Rh2 (3beta,12beta,20R)-12,20-Dihydroxydamm-24-en-3-yl beta-D-glucopyranoside 20R-Ginsenoside Rh2 //BP GINSENOSIDE Rh2 (R-FORM) (20R)-12beta,20-Dihydroxydamm-24-en-3beta-yl beta-D-Glucopyranoside Ginsenoside Rh2, 20(R) 20(R)-Ginsenoside-Rh2 20(R)-Ginsenoside Rh2, 10 mM in DMSO b-D-Glucopyranoside, (3b,12b,20R)-12,20-dihydroxydammar-24-en-3-yl (R) Ginsenoside Rh2 (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-d-glucopyranoside β-D-Glucopyranoside, (3β,12β,20R)-12,20-dihydroxydamm-24-en-3-yl 20-(R)-Ginsenoside Rh2 β-D-Glucopyranoside, (3β,12β,20R)-12,20-dihydroxydammar-24-en-3-yl 20(R)-GINSENOSIDERH2 (R-type) ginsenoside Rh2 |
| Description | 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.19 |
|---|---|
| Boiling Point | 726.4±60.0 °C at 760 mmHg |
| Melting Point | 225 °C |
| Molecular Formula | C36H62O8 |
| Molecular Weight | 622.873 |
| Flash Point | 393.1±32.9 °C |
| Exact Mass | 622.444458 |
| PSA | 139.84000 |
| LogP | 5.62 |
| Vapour Pressure | 0.0±5.4 mmHg at 25°C |
| Index of Refraction | 1.572 |
|
~%
112246-15-8 |
| Literature: Atopkina, Lyubov N.; Uvarova, Nina I.; Elyakov, Georgi B. Carbohydrate Research, 1997 , vol. 303, # 4 p. 449 - 451 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |